Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics

Molecular heterogeneity in metastatic breast cancer presents multiple clinical challenges in accurately characterizing and treating the disease. Current diagnostic approaches offer limited ability to assess heterogeneity that exists among multiple metastatic lesions throughout the treatment course....

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Allen, Keck, Jamie M., Parmar, Swapnil, Patterson, Janice, Labrie, Marilyne, Creason, Allison L., Johnson, Brett E., Downey, Molly, Thomas, George, Beadling, Carol, Heiser, Laura M., Kolodzie, Annette, Guimaraes, Alexander R., Corless, Christopher L., Gray, Joe W., Mills, Gordon B., Bergan, Raymond C., Mitri, Zahi I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997873/
https://www.ncbi.nlm.nih.gov/pubmed/33772089
http://dx.doi.org/10.1038/s41698-021-00165-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997873/
https://www.ncbi.nlm.nih.gov/pubmed/33772089
http://dx.doi.org/10.1038/s41698-021-00165-4

Ejemplares similares